Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion type Assertion NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_head.
- NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion description "[Mutations in GABRA1, GABRG2, and GABRB3 are associated with absence seizures, while mutations in CLCN2 and myoclonin/EFHC1 substantiate juvenile myoclonic epilepsy as a clinical entity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_provenance.
- NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion evidence source_evidence_literature NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_provenance.
- NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion SIO_000772 16302874 NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_provenance.
- NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion wasDerivedFrom befree-2016 NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_provenance.
- NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_assertion wasGeneratedBy ECO_0000203 NP523552.RAOLqF1fMa7MRSxAPG3xBwADM-mKKia5rpdt7Db69zg2w130_provenance.